Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134864) titled 'Research on Prostate Cancer Carbon Ion Adaptive Radiotherapy Trigger Decision Method' on Oct. 21.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: The Clinical Technology Research And Development Center of Shanghai Proton and Heavy Ion Center
Condition:
prostate cancer
Recruitment Status: Recruiting
Phase: Retrospective study
Date of First Enrollment: 2026-10-26
Target Sample Size: Research queue on carbon ion adaptive radiotherapy triggering decision method for prostate cancer:25;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?pr...